TAVR: High Implantation of Self-Expanding Valves Directly Impacts ECG

TAVR has been shown beneficial, especially in high risk or inoperable patients. However, there are limitations to its use, especially with self-expanding valves, which are the need for pacemaker implantation and ECG changes after procedure. 

TAVI: el implante alto de las válvulas autoexpandibles impacta directamente en el ECG

To address this matter, researchers assessed the right and left cusp overlap effect on 254 patients undergoing TAVR with self-expanding valves. 162 of these patients were treated with the traditional technique (TT), and 92 with the cusp overlap technique (COT).

The primary endpoints were ECG changes and a combined endpoint including pacemaker implantation, hospitalization, or cardiovascular death at 1 year. To match for differences in the populations, propensity score was used, resulting in 92 patients in each group.   

Mean patient age was 83, half were men and most of them presented hypertension; 23% were diabetic, 16% had peripheral vascular disease and 12% MI. 

Ejection fraction was conserved, mean gradient was 46 mmhg, and valve aortic area was 0.70 cm2.

Read also: Use of IVUS in Complex PCI: Results according to Operator Experience.

Offset ECG had shown 22% atrioventricular block (AVB), 12% left bundle branch block (LBBB), 12% right bundle branch block (RBBB), and 8% high grade atrioventricular block (HGAVB).

During the procedure, there were no significant differences in pre or post dilation, and mean valve diameter was 29 mm. 

24 hours after procedure, COT group showed lower incidence of LBBB, and less P and QRS wave prolongation. 

At one year, COT showed a significant reduction of LBBB (49% vs. 27% p=0.002), and less P wave (13.1±21.0 msec vs 5.47±12.5 msec; P=.003) and QRS prolongation (29.77±27.0 msec vs 16.38±25.4 msec, P <.001), with a significant reduction in the combined primary endpoint (SHR, 0.39 [CI95%, 0.21-0.76]; P=.005) 

Read also: Dissection and Re-Entry Technique in Chronic Total Occlusions: Data from the PROGRESS-CTO Registry.

Even though there were no significant differences in mortality, cardiovascular and all-cause hospitalizations were higher in the TT group. 

Although there were no significant differences, the need for pacemaker implantation was numerically lower in the COT group (15.2% vs 10.9%, p=0.376).

Conclusion

After one year, TAVR with COT showed lower incidence of LBBB and lower alteration of P and QRS waves vs. TT. COT was associated with a statistically significant reduction of the combined cardiovascular end point. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Self-expanding TAVI using the cusp overlap technique versus the traditional technique: electrocardiogram changes and 1-year cardiovascular outcomes.

Reference: Yva´n R. Persia-Paulino, et al. Rev Esp Cardiol. 2024;77(1):29–38.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology


More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...